Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.

慢性心衰竭合併射血分數降低患者使用 Vericiguat（VICTOR）：一項雙盲、安慰劑對照、隨機、第三期臨床試驗